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ABSTRACT 
 
Neurotropism of Theiler’s Murine Encephalomyelitis Virus. (August 2005) 
Dorissa Villarreal, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Jane Welsh 
 
Theiler’s murine encephalomyelitis virus (TMEV) can infect the central nervous 
system (CNS) and cause neurological damage. The exact route by which TMEV enters 
the CNS remains unknown. Two hypotheses suggest that TMEV enters the CNS either 
by the neural and/or the hematogenous pathway.  To explore these hypotheses, the 
GDVII strain of Theiler’s virus was inoculated via different routes in susceptible mice.  
The incidence of paralysis and/or encephalitis was evaluated. The forms of paralysis 
displayed corresponded to the site of viral inoculation.  Following intramuscular (i.m.), 
intraperitoneal (i.p.), intravenous (i.v.) and footpad routes of injection, bilateral and or 
contralateral paralyses were observed.  In mice injected intratongue, tongue paralysis 
was observed.  Intracranial (i.c.) injections resulted in 100% mortality.  A detailed time 
course experiment was also completed which focused on the neural transport pathway 
used by TMEV to invade the CNS.  The GDVII strain of Theiler’s virus was injected 
into the left gastrocnemius muscle and the hypoglossal nerve (CN XII).  The incidence 
of paralysis and/or encephalitis was evaluated on the basis of clinical signs, 
immunofluorescent analysis, and histopathology.  Following the i.m., route of injection, 
unilateral hind limb paralysis was observed in the injected limb and a weakening of the 
 iv
contralateral limb was also observed.  In mice injected in the hypoglossal nerve, tongue 
paralysis was observed.  Also, the penis of most affected males was prolapsed.  The 
localization of viral antigen using fluorescent labeling correlated with the clinical signs 
of paralysis for both injections. The studies reported here support the theory that GDVII 
Theiler’s virus may gain access to the CNS through a neural transport pathway. 
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INTRODUCTION 
History 
 Motor neuron disease is a term applied to neurodegenerative diseases that 
involve a loss of lower motor neurons and/or upper motor neurons of the central nervous 
system (CNS) [1].  The clinical signs associated with motor neuron diseases are 
characterized by a progressive weakening of the skeletal muscle affected that leads to 
atrophy and paralysis.  Many studies suggest that the onset of motor neuron diseases can 
be associated with a number of factors. These include infectious etiology, genetic 
inheritance, and environmental triggers [2].  At the present time there is no cure for these 
types of neurological diseases, however, the use of animal models of motor neuron 
diseases have provided an understanding of their causes and the pathogenesis.   
 One notable model of importance is Theiler’s Murine Encephalomyelitis Virus 
(TMEV) infection in mice.  Max Theiler, a South African – American research 
physician, originally isolated TMEV in 1933 from the CNS in mice that developed 
flaccid paralysis of the hind limbs [3].  Following this observation, he reproduced these 
results by injecting mice via intracranial and intranasal sites [3,4].  The mice developed 
paralysis within weeks post infection, and he also observed lesions in the ventral horn of 
the spinal cord.  He used his discovery as an animal model of human poliomyelitis.  
Theiler is largely known for his work on TMEV and yellow fever.   
 
This thesis follows the style of Microbial Pathogenesis. 
 
 
  
2
In 1951, he was awarded the Nobel Prize in Medicine for his work on yellow fever.  
Following his pioneering work on TMEV, new strains have been isolated that have the 
capability of persisting in the CNS and causing an inflammatory disease of the CNS [5].  
The inflammatory demyelination of the CNS seen in TMEV resembles Multiple 
Sclerosis, and is used as an animal model for this disease.  The significance of this 
model system for studying Multiple Sclerosis and other neurological diseases is that the 
model is well characterized and the virus will readily infect susceptible mice.  Also, 
because it only affects genetically susceptible mice it can be used as an animal model of 
neurological diseases caused by genetic factors.  Lastly, it is an excellent model to study 
immune-mediated pathogenesis. 
Virology  of Theiler’s virus  
Theiler’s murine encephalomyelitis virus TMEV is a member of the 
Picornaviridae family and belongs to the genus cardiovirus [6].  The genome of 
Theiler’s virus is an 8 kb-long positive strand RNA molecule.  After entry of the virus 
into the host cell, it will immediately begin the replication cycle in the host cell 
cytoplasm.  The RNA strand is polyadenylated at the 3’ end.  At the 5’ end it contains a 
small protein covalently linked termed, VPG [7].  TMEV RNA includes a large open 
reading frame that encodes a 2000 amino acid – long polyprotein.  During translation, 
the chain is cleaved into 12 mature proteins by autoproteolytic activity.  Translation of 
the open reading frame is initiated by the internal ribosome entry site located at the 5’ 
non-coding region.  The persistent strains of TMEV have an additional open reading 
frame that encodes an 18-kDa leader ( L ) protein.  The function of the L protein was 
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shown to facilitate in the infection of Theiler’s virus and viral persistence [8, 9].  TMEV 
also contains 4 polypeptide chains VP1, VP2, VP3, and VP4 that assemble to form the 
viral capsid (Fig. 1).  The role of protein 2A is unknown; however, some picornaviruses 
such as poliovirus use 2A to cleave VP1 from the newly translated polyprotein [7].  3B 
also termed VPG is covalently linked to the 5’ end, and 3B is used during encapsulation 
and replication.  3C is the proteinase that is responsible for the majority of the 
polyprotein cleavages.  3D is the RNA-dependent RNA polymerase, and proteins 2B, 
2C, and 3A are used in the replication cycle (Fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VP4 
Ld VP2 VP3 VP1 2A 2B 2C 3A 3C 3D
3B
IRESa 
CAPSIDb REPLICATIONc 
Figure 1.  Theiler’s virus genomic organization. 
a IRES at 5’ end for translation initiation 
b polypeptide chain, VP1, VP2, VP3, & VP4, used in capsid assembly 
c  proteins 2A, 2B, 2C, 3A, 3B, 3C, & 3D used in replication cycle 
d L protein function largely unknown 
  
4
Classification of Theiler’s virus   
Theiler’s virus is a naturally occurring enteric pathogen of mice and in early 
disease causes poliomyelitis-like flaccid paralysis in mice [6].  Theiler’s viruses are 
divided into two subgroups: GDVII and Theiler’s Original (TO).  The GDVII group is 
extremely neurovirulent and induces acute fatal polioencephalomyelitis without 
demyelination.  The TO group is less neurovirulent and includes the BeAn and DA 
strains. These strains cause a biphasic disease in which the early phase is characterized 
by an acute encephalomyelitis.  If the virus persists, the animals will develop a chronic 
demyelinating disease in the CNS.  This phase resembles multiple sclerosis in humans, 
and therefore is used as an animal model [5]. 
The mechanism behind the ability of GDVII virus to primarily infect neurons in 
the gray matter, but not infect glial cells in the white matter of the spinal cord is largely 
unknown.  In contrast, the DA virus has the ability to infect neurons in the gray matter 
during the acute phase and persistently infect glial cells and macrophages in the white 
matter during the chronic phase.  Although this suggests GDVII may not have the ability 
to travel along axons effectively, GDVII strain has been shown to be transported along 
axons by other experiments [10, 11, 12].  Attenuated GDVII strains that were obtained 
by mutations on the 5’ noncoding region of the genome do not kill the host, however, 
they are unable to persist in the host [13].  One study suggests that differences between 
DA and GDVII are possibly due to the severity and rapid degeneration of axons does not 
allow the transport and spread of GDVII from the gray matter to the white matter.  In 
this study immunohistochemical analysis of axonal pathology indicates axonal injury in 
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both DA and GDVII; however the extent of injury in the acute phase of DA compared to 
GDVII infection, indicates slower development of axonal injury [12].  Other studies 
demonstrate difference(s) in the virus-host receptor-binding site between GDVII and DA 
viruses that may contribute to the difference in host cell tropism and species specificity. 
Several studies have mapped the regions of the viral genome responsible for persistence 
and demyelination at the surfaces of the capsid [14, 15].  Some studies show that 
persistent but not neurovirulent strains of Theiler’s virus use sialic acid for entry [14].  
Pathogenesis 
Theiler’s Murine Encephalomyelitis virus (TMEV) is a natural enteric pathogen 
of mice that causes asymptomatic infection.  In rare occasions the virus will invade the 
central nervous system (CNS) and cause neurological disease.  The mechanism of entry 
of TMEV to the CNS is unknown.  However, studies with poliovirus, the causative agent 
of poliomyelitis in humans, and like TMEV is within the Picornaviridae family [16], has 
shown that TMEV shares many biological characteristics in common with poliovirus. 
Similar to TMEV, in nature, poliovirus is spread from host to host via the fecal-oral 
route or the oropharyngeal-oral route [17, 18].  After ingestion the virus replicates in the 
walls of the pharynx or the lower gastrointestinal tract, spreads to local and regional 
lymphatic tissue, and then invades the blood stream before penetrating and replicating in 
the nervous system [19].  However, it may be possible after alimentary infection, for 
poliovirus to infect the regional ganglia cells and then invade the nervous system. 
Two hypotheses suggest that TMEV enters the CNS either by the neural and/or 
the hematogenous pathway.  It is postulated that invasion of the CNS by TMEV is via 
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the circulation and crossing the blood-brain barrier (BBB) or through lymphatic channels 
[20].  The BBB is composed of specialized cerebrovascular endothelial cells, which 
restrict vesicular transport and protect the CNS from harmful substances circulating in 
the blood.  Hematogenous virus entry into the CNS may involve endothelial cells and/or 
macrophages. Viral RNA of TMEV has been detected in vascular endothelial cells, 
neurons and glial cells in the brains and spinal cords [21].  TMEV has also been shown 
to replicate in brain endothelial cells in vitro [22].  Moreover, mononuclear cells isolated 
directly from the CNS inflammatory infiltrates of TMEV infected mice were found to 
contain infectious viral antigens, and TMEV was found to replicate in brain 
macrophages.  This experimental evidence strongly suggests that TMEV may enter the 
CNS through the hematogenous circulation and cross the BBB by infecting and 
replicating in the endothelial and/or inflammatory cells. 
Studies with poliovirus (PV) suggest that after i.v inoculation, poliovirus may 
enter the CNS through the BBB at a fairly high rate although it is not known how 
poliovirus permeates the BBB[17].  One experiment using human poliovirus receptor 
(hPVR) supports the hematogenous pathway.  For instance, hPVR was expressed on 
monocyte/macrophages from peritoneal samples.  In addition, 26–32% of hPVR 
transgenic bone marrow and spleen cells express CD155 poliovirus receptor (PVR) on 
monocyte/macrophages, T cells and hematopoietic precursor cells [23].  The 
identification of PV in monocytes may provide insight into PV pathogenesis, such as 
transport of the virus into the CNS.  These findings also indicate that these cells might be 
involved in poliovirus replication during poliomyelitis.  
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Several studies also suggest that the main viral dissemination route for Theiler’s 
virus may occur by infection of peripheral organs, such as muscle, followed by viral 
entry from these secondary sites via peripheral neural routes [10, 11, 12, 24].  One 
particular study injected virus in the left hind limb of susceptible mice.  Upon, 
histological analysis the spread of GDVII virus from the periphery to the inferior spinal 
cord through the sciatic nerve and then the anterior spinal cord segment was evident.  
After nerve transection of the sciatic nerve no viral RNA was detected in the inferior 
spinal cord up to 4 days p.i [10].  These findings suggest that the mechanism of transport 
of the GDVII virus is by fast axonal transport.  CNS infection may occur by infection of 
skeletal muscle followed by entry of the virus via peripheral neural routes.  Myelinated 
motor nerves branch out from the CNS and innervate skeletal muscles.  TMEV may 
infect the motor neurons, and then be transported retrogradely along the axons of motor 
neurons and hence to invade the central nervous system.  The study of entry into the 
CNS and dissemination of the virus in the CNS is important in understanding the disease 
pathogenesis.   
Mice injected via the intracranial route with GDVII Theiler’s virus do not 
develop paralysis [3,4].  This is a consequence of the high neurovirulence of GDVII in 
susceptible mice.  However, the distribution of DA virus, a less neurovirulent strain of 
TMEV, in the spinal cord after intracerebral inoculation has been evaluated by 
immunohistochemistry [25].  In the early stage of infection viral antigens were detected 
in the motor neurons of the anterior horn.  TMEV may gain access to the anterior horn 
cells from the brain through the corticospinal tract or the ventral root entry zone. 
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Immunohistochemical analysis detected viral antigens in glial cells of the corticospinal 
tract, which would support the neuronal route [25].  However, entry of TMEV to the 
anterior horn of the spinal cord may allow access through the ventral root entry zone. 
The blood-brain barrier in this region is more “leaky” and may be vulnerable during 
viral infection [20].  In addition, within the anterior horn the axons of motor neurons are 
composed mainly of ventral roots.  This is consistent with retrograde invasion from the 
ventral nerve entry zone to the anterior horn cells [25].  The presence of viral RNA in 
the endothelial cells of blood vessels was also identified in this study [25]. 
 Experiments using neonatal mice to demonstrate the route of viral spread from 
the gastrointestinal tract to the CNS were performed [26].  Using kinetic analysis, viral 
titers were used to measure viral spread in mice inoculated orally with the DA strain.  
These results showed higher titers in well-vascularized tissues such as the spleen and 
liver compared to the CNS [26].  Moreover, pathological studies revealed that infected 
neurons were found in areas of the CNS that are not directly connected via axons to 
peripheral organs, such as the muscle.  After intranasal inoculation with poliovirus, the 
virus spreads to the hypothalamus, from there to the thalamus and, hence through the 
spinothalamic tract, to the lumbar cord [27].  However monkeys can no longer be 
infected with poliovirus if the olfactory bulbs or tracts were removed, or the neuronal 
pathway was inhibited by chemical agents such as aluminum sulfate, nitrophenol, 
trinitrocresol, mercurochrome or zinc sulfate [27]. 
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Neuropathology of TMEV 
Following intracranial injection of GDVII, inflammatory infiltrates of the 
leptomeninges can be seen as early as 1- 2 days post infection (3, 4, 6).  The 
inflammatory infiltrates seen consist of lymphocytes and monocytes/macrophages [6].  
An acute viral encephalomyelitis is evident with an intense inflammatory mononuclear 
cell infiltrate in the gray matter.  No lesions are seen in the white matter.  Perivascular 
mononuclear cell infiltrates are also present.  After some time the infected neurons start 
to undergo degenerative changes or cell death by apoptosis.   
Cell death by apoptosis usually occurs in isolated cells, and does not disrupt 
other living cells surrounding it [28].  This process is sometimes referred to as 
programmed cell death because it requires initiating signals of a cell to undergo 
apoptosis that can come from outside or inside the cell.  Also, sequential activation of 
proteases serves to amplify the signal and allow a rapid end to the cell.  The 
mitochondria also play an important role in that it serves to integrate several signals for 
apoptosis.  The morphological appearances of a normal cell undergoing apoptosis are 
distinct.  Once the normal cell receives overriding signals to undergo apoptosis it first 
appears irregularly contoured and shrunken away from neighboring cells [28].  Pyknosis 
then occurs, which is characterized by the nuclear chromatin undergoing dense 
condensation.  Small pieces of the cell containing condensed chromatin begin to break 
off into apoptotic bodies.  In light microscopy apoptotic bodies have dense nuclear 
chromatin with little eosinophilic cytoplasm, and are clearly separated from surrounding 
cells.  The pieces then are taken up by phagocytic cells especially macrophages, and they 
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are gradually ingested.  The significance of macrophages in the removal of apoptotic 
bodies lies in the macrophages ability to ingest these bodies without the release of 
cellular constituents, thereby causing no inflammatory response.   Macrophages are 
derived from blood monocytes that migrate out of the blood vessel and have become 
activated in the tissue in response to certain chemotaxic stimuli [29]. 
Cells of the immune system 
Inflammation is the tissues response to irritation or injury.  It allows defensive 
factors to gain access to the site of irritation or injury.  The cells of the immune system 
circulate throughout the blood and lymphatic channels [29].  The cells will migrate to 
tissues in response to a pathogen or injury.  The type of cells found in a particular tissue 
is important to understanding the type of injury involved.  Microbial infections, 
hypersensitivity reactions, physical agents, chemicals, and tissue necrosis may instigate 
the onset of acute inflammation [29].  The essential physical characteristics of acute 
inflammation are redness of inflamed tissue, increase in temperature due to increase 
blood flow, swelling due to the accumulation of edema fluid in the extravascular space, 
and pain due to inflammatory edema [30].  Loss of function may also be a consequence 
of acute inflammation due to the pain and swelling. The cells mainly seen in the early 
immune response to an antigen are mast cells, dendritic cells, neutrophils, 
monocytes/macrophages, and natural killer cells (NK) [29].  Although there is degree of 
overlap between the early immune response and the later acquired immune response, 
immune cells, B lymphocytes and T lymphocytes, infiltrate lesions later [29].  The 
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clinical signs described earlier are due to systemic effects induced by these cells and 
tissue mediators, which will be discussed in the next few paragraphs. 
Mast cells circulate in the blood, but are mainly found in the connective tissue of 
the skin, gastrointestinal tract and respiratory tract [29].  They are large, round cells, 
whose cytoplasm is packed with large granules.  Upon stimulation with complement 
components they release inflammatory mediators stored in their granules [ 29].  One 
inflammatory mediator released is histamine.  Histamine is a vasoactive factor causing 
dilation of arterioles and enhancing the early phase of vascular permeability of venules.  
Mast cell secretion of histamine causes the release of TNF-α from macrophages.  The 
effect of these substances increases vascular permeability and therefore contributes to 
the acute inflammatory response [29].  Mast cells are well known for their roll in allergic 
responses.  However, they also express several pattern recognition molecules that can 
alter the immune response, and can respond to both bacterial and viral products.  
The neutrophils contain granules in their cytoplasm that stain pink with H&E.  
They are predominately phagocytic cells of the early immune system that usually are 
evident in high numbers with bacterial infections [29].  They destroy bacteria, and cell 
debris through a process called phagocytosis.  In phagocytosis the neutrophil flows over 
and binds to foreign material.  It is then drawn into the cell where the cytoplasm then 
encloses it in a phagosome.  Lysosome of the neutrophil attaches to the phagosome, and 
releases enzymes into it that break down and digest the foreign material. They are 
mainly found circulating in the blood.  The initiation of neutrophils into the extracellular 
space is mediated by a change in blood cell flow within the lumen of the larger blood 
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vessels [30].  Normally blood cells flow in the center of the lumen while plasma flows 
near the vessel walls, however, a loss of intravascular fluid and an increase in plasma 
thickness causes a slowing of blood flow.  This allows neutrophils to occupy positions 
along endothelial surfaces.  Once neutrophils are along sites of injury they come into 
contact with adhesion molecules [30].  There are several types of adhesion molecules 
that are increased by chemical inflammatory mediators.  Some act as lectins that bind to 
carbohydrates on leukocytes. These surface adhesion molecules may be expressed by 
complement components, leukotriene B4, and tumor necrosis factor.  Other classes are 
called selectins which establish the first loose contact between leukocytes and 
endothelium resulting in the rolling action.  Also, included among adhesion molecules 
are integrins, and intercellular adhesion molecule–1.  These increase the leukocyte-
endothelium surface adhesion molecule bond.  The expression of selectins is mediated 
by interleukin-1, endotoxins, and tumor necrosis factor.  
Macrophages are derived from blood monocytes that migrate out of the blood 
vessel and have become activated in the tissue in response to chemotaxic stimuli as 
described earlier [29,30,31].  Macrophages belong to a group of the mononuclear 
phagocytic system.  Unlike neutrophils, inflammatory macrophages are able to undergo 
phagocytic activity repeatedly, and can remove dead, dying and damaged tissue.  
Macrophages can also process and present material to lymphocytes.  Additionally, 
macrophages secrete numerous chemical mediators.  Although macrophages do have this 
capability, dendritic cells are specialized cells whose main function is to take up antigen 
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and display it for recognition by lymphocytes.  They circulate in the blood and are also 
found in the tissues.  
In nervous tissue, microglia are regarded as bone marrow derived monocytes that 
enter the central nervous system (CNS) in the early stages of development [32].  A 
number of microglia are able to actively phagocytose, process and present antigens to 
immune cells.  MHC class II molecules have been detected in resident microglia [32].  
More specifically, there is an increased expression of MHC class II molecules on 
microglia that have been exposed to pro-inflammatory cytokines [32].  Microglia are 
sources of cytokine production such as IL-10 and IL-15 that regulate the response of 
cells in the adaptive immune system.  They express CD14 receptor for 
lipopolysaccharide, which is a cell wall component of gram-negative bacteria [32].  Due 
to their ability to process and present antigens and induce immune responses they can 
significantly compromise the blood-brain barrier (BBB) [32].  
Natural killer cells are T cell precursors that contain cytotoxic molecules [29].  
These molecules include perforin and granzyme that are capable of killing virally 
infected cells [29].  These cells are activated by IL-12 secreted by macrophages.  Unlike 
T cells they do not need to recognize specific epitopes of viral antigen, and therefore are 
a part of the early immune response.  In contrast, the later acquired immune response 
includes B cells and T cells.  B cells differentiate into plasma cells that secrete 
antibodies [29].  T cells can differentiate into cytotoxic T cells, that kill virally infected 
cells, or they can differentiate into T cells that activate B cells and macrophages [29].  
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T cells infiltrating the CNS are those that have been recently activated or 
memory cells.  Moreover, only T cells that express specificity to CNS antigens are 
retained within the brain parenchyma [32].  Upon activation newly expressed adhesion 
molecules direct T cells to inflamed sites.  T cells express adhesion molecules, integrins, 
and intercellular adhesion molecule–1 [33], which increases the leukocytes-endothelium 
surface adhesion molecule bond.  These are a group of selectins that are chemically 
mediated by interleukin-1, endotoxins, and tumor necrosis factor [33].  After, binding to 
the endothelial surface, inflammatory cells migrate through the walls of venules and 
small veins [33].  T cell infiltrates followed by other inflammatory cell infiltrates such as 
monocytes are another source of pro inflammatory mediators that are highly regulated in 
the brain and spinal cord [32].          
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OBJECTIVES 
 The exact route by which TMEV enters the CNS remains, for the most part, 
unknown.  Two hypotheses suggest that the virus enters the CNS either by the neural 
and/or the hematogenous pathway.  To explore these hypotheses, a preliminary study 
was done that focused on understanding the mechanisms of entry of Theiler’s virus 
GDVII into the CNS using different sites of exposure, and the pathway the virus takes 
once in the CNS.  The following inoculation sites using GDVII strain were carried out:  
intramuscular (i.m.), intraperitoneal (i.p.), intrafootpad, intratongue, intracranial (i.c.) 
injections, and intravenous (i.v.) injections.  The results obtained in this preliminary 
experiment showed that TMEV is capable of accessing the neural route with out 
accessing the hematogenous route..  Additionally, once TMEV enters the CNS it is 
capable of traveling throughout the CNS via the nervous circuitry.  The neural transport 
pathway hypothesis was further tested in this thesis.  In particular a time course 
experiment was performed following injection of the hypoglossal nerve, or 12th cranial 
nerve, and injection of the left gastrocnemius muscle.   
To explain the route of entry and dissemination pathway involved in TMEV 
pathogenesis, the virus was injected intramuscularly into the left gastrocnemius muscle 
of susceptible mice.  A detailed time course experiment was performed using the GDVII 
TMEV strain, which was injected into the left gastrocnemius muscle of 4-week-old male 
CBA mice.  After injection, the mice were sacrificed on days one, two, three, four, five, 
and six post-infection.  Mice injected with GDVII TMEV were also observed for any 
incidence of paralysis including rear and/or fore limb paralysis up until the time of 
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sacrifice.  Histopathological evaluation was carried out on the mice following 
intramuscular injection with GDVII Theiler’s virus.  Histopathological examination of 
the CNS of all mice was evaluated by observing the severity of inflammation present on 
the different days of post infection.  The CNS lesions include mononuclear cell 
infiltrates and perivascular cuffing.  The correlation between the extent of neuronal 
destruction and the severity of rear limb paralysis and/or fore limb was also evaluated.  
The specific neurotransmission of TMEV in the spinal column to the medullary areas of 
the brain was determined by immunofluorescence studies using a purified polyclonal 
rabbit anti-GDVII virus.   
To explain the route of entry and dissemination pathway, an intranerve injection 
of TMEV into the 12th cranial nerve of susceptible mice was also performed.  A detailed 
time course experiment using the GDVII TMEV strain was performed by injecting in the 
12th cranial nerve, the hypoglossal nerve.  After injection, a total of four mice were 
sacrificed on days one, two, three, four, five, six, and seven post-infection.  Mice 
injected with GDVII TMEV were also observed for any incidence of paralysis, including 
tongue paralysis.  Histopathological evaluation was also carried out on the mice 
following hypoglossal nerve injection with GDVII Theiler’s virus.  Any evidence of 
mononuclear cell infiltrates and perivascular cuffing was noted.  The correlation of the 
extent of neuronal destruction in the brain with the tongue paralysis and/or other clinical 
signs was evaluated.  The specific neurotransmission of TMEV into the medullary areas 
of the brain and also in the spinal cord was determined by immunofluorescence studies 
using a purified polyclonal rabbit anti-GDVII virus.   
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RESULTS 
Preliminary experiment gastrocnemius muscle injection of TMEV  
Experimental evidence indicates a possibility of CNS invasion of TMEV by 
infection of skeletal muscle followed by entry of the virus via peripheral neural routes. 
Mice injected with GDVII Theiler’s virus into the left gastrocnemius muscle showed 
signs of paralysis.  Mice injected with GDVII Theiler’s virus into the left gastrocnemius 
muscle showed flaccid paralysis between day 2 and 4 p.i.  The initial state of paralysis 
was first observed in the injected rear limb.  Most mice showed weakness or unilateral 
flaccid paralysis on the injected rear limb by day 3 p.i.  A corresponding paralysis of the 
contralateral limb is seen in 100% of mice that are initially injected in the left 
gastrocnemius muscle with GDVII virus.  Weakening of the contralateral rear limb was 
evident on day 4, and by day 5 p.i. bilateral paralysis on both rear limbs was evident. 
Usually one of the fore limbs showed involvement by day 6 p.i.  The results indicate that 
the spread of GDVII virus may occur from the periphery to the inferior spinal cord.  The 
virus then travels along interneurons where it then crosses over to the contralateral limb. 
If this paralysis was allowed to progress mice usually developed complete bilateral 
forelimb and bilateral rear limb paralysis by day 6 p.i.  The incidence of paralysis for 
GDVII Theiler’s virus was 100%, therefore all injected mice showed paralysis.  
Preliminary experiment intrafootpad injection of TMEV 
Results obtained from mice injected into the left footpad had similar results as 
those of the i.m. injections with GDVII.  The GDVII virus can infect and kill CNS 
neurons efficiently.  It is able to spread from the periphery to the spinal cord through the 
  
18
sciatic nerve were it will cause paralysis initially in the inoculated limb.  All mice were 
injected with GDVII strain in the left hind footpad and were examined daily for clinical 
signs.  The typical course of the disease was paralysis of the inoculated limb 2 to 4 days 
p.i., followed by contralateral rear limb paralysis 1 to 2 days p.i.  Unilateral forelimb 
paralysis was also evident by day 6 p.i.  These results were consistent with those results 
obtained from i.m. injections; indicating the spread of the GDVII strain from the 
periphery to the CNS via the sciatic nerve.  
Preliminary experiment intraperitoneal of injection of TMEV 
Upon i.p. injection of GDVII Theiler’s virus into the peritoneal cavity mice 
developed flaccid paralysis either in the rear limbs and/or the fore limbs.  Most infected 
mice developed paralysis in the rear-limb first, and by day 6 p.i. all mice developed fore 
and rear limb paralysis.  The percentage of mice that developed flaccid paralysis was 
100%.  There are a few possibilities of CNS invasion by means of the i.p route. Viral 
entry through the abdominal sympathetic trunk, which supplies preganglionic fibers 
throughout the abdominal and pelvic regions, is one possibility.  Other possibilities 
include direct invasion of the CNS from the bloodstream, or by infection of peripheral 
organs, such as muscle, followed by viral entry from these secondary sites via peripheral 
neural routes.  
Preliminary experiment intravenous injection of TMEV  
Mice inoculated directly into the bloodstream with GDVII Theiler’s virus 
showed flaccid paralysis either in the rear limbs and/or the fore limbs.  Most infected 
mice developed weakening in the rear-limb and forelimb by day 3 p.i.  Mice infected 
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usually fully developed paralysis by day 4 p.i.  Following the intravenous injection with 
GDVII Theiler’s virus 80% of the mice showed at least one form of paralysis.  
Preliminary experiment intracranial and intratongue injection of TMEV  
 All mice inoculated i.c. with GDVII Theiler’s virus died within 48 hrs p.i. 
Clinical signs of encephalitis were evident within 24 hrs.  Clinically, encephalitis was 
observed by neck and arched back, and a ruffled fur appearance.  All mice injected with 
GDVII Theiler’s virus intratongue develop tongue paralysis by day 4 p.i.  Other clinical 
results were similar to those for the intracranial injection.  The clinical signs in mice 
injected in the tongue were arched back, ruffled fur, and tongue paralysis. 
Preliminary experiment histopathological studies 
Histopathological review was performed following most routes of injection with 
GDVII Theiler’s virus.  Following, intravenous and intraperitoneal routes of injection 
mice were sacrificed by day 6 p.i.  Following, intramuscular, intratongue, and 
intrafootpad route of injection mice were sacrificed by day 6 p.i.  Following, intracranial 
inoculation mice were found dead by day 2 p.i. or administered a lethal dose of 
anesthetic. Upon histological examination a varying severity of inflammation was 
present between different routes of injection. The lesions present in the CNS included 
mononuclear cell infiltrates and perivascular cuffs. The extent of neuronal destruction 
was consistent with the severity of rear limb paralysis and/or forelimb paralysis.  The 
non-infected group did not show any evidence of microgliosis or perivascular cuffing 
(Fig. 2 (A)). 
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 Of the animals that displayed bilateral hind limb paralysis histopathological 
evaluation indicated that there was inflammatory infiltration in the gray matter of the left 
and right anterior horn (Fig. 2 (B)).  Inflammatory mononuclear infiltrates as well as 
degenerated and necrotic neurons in the gray matter of the left and right anterior horn in 
the upper lumbar segment of the spinal cord were evident (Fig. 2 (C, D)).  The mice that 
displayed forelimb paralysis had a significant amount of inflammatory infiltrates and 
neuronal loss in the cervical spinal cords (Fig. 2 (F)).  The mice that showed bilateral 
rear limb and unilateral forelimb paralysis histopathological evaluation indicated that 
inflammation was apparent throughout the lumbar and cervical sections of the spinal 
cord (Fig. 2 (E, F)).  In the spinal cord meningitis was most prominent in i.m., i.f., i.v., 
and i.p. injections. Small patchy areas of inflammatory infiltrates were seen in most 
routes of injection. Inflammation did not appear to be confined to a specific area.    
 The severity and distribution of lesions in the spinal cord correlated with clinical 
disease.  Paralyzed animals invariably showed inflammation and neuronal degeneration 
in the spinal cord of paralyzed mice. Moreover, the sites of lesions in the spinal cord of 
paralyzed animals consistently corresponded to the distribution of clinical paralysis. 
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Figure 2.  H&E photomicrographs of cross sections of spinal cord sections in preliminary 
experiment.  Panels A, B, C, E, & F were taken at 10X.  Panels D were taken at 63X.  (A) NIF 
mouse.  (B,C) IF mouse section that shows ventral lateral meningitis on the left and right side.  
Also, Dorsal lateral meningitis on right side.  (D) High mag of (C) showing microgliosis  in the 
left ventral gray matter and degenerated neurons.  (E,F) Inflammatory infiltration of the meninges, 
perivascular cuffing, and microgliosis.  
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The development of paralytic disease caused by several routes of inoculated 
Theiler’s virus GDVII was investigated using susceptible mice. The incidence of 
paralysis and the anatomical location of paralysis corresponded to the different routes of 
injection with GDVII Theiler’s virus (Table 1). Bilateral and/or contralateral paralysis 
was observed following the intramuscular, intravenous, intraperitoneal, and footpad 
routes of injection. All mice injected intratongue showed signs of tongue paralysis. The 
intracranial route of injection resulted in 100% mortality and clinical encephalitis. This 
data indicates that both IV and IM inoculated with TMEV can enter the CNS and 
replicate in neurons. 
 
 
  Table 1.  Specificity of paralysis due to routes of injection of TMEV 
Route of 
Injectiona 
Volume of 
Virusb 
pfu injectedc Paralysis or 
Mortalityd 
Day of 
Paralysise 
Clinical 
Encephalitisf 
Intramuscular 100ul 106    pfu URLP/BRLP 
paralysis 
2-4 0 
Intragastric 100ul 106    pfu 0% 0 0 
Intravenous 100ul 106    pfu Fore/rear limb 
paralysis 80% 
6 0 
Intraperitoneal 100ul 106    pfu Fore/rear limb 
paralysis 100% 
6 0 
Intratongue 100ul 106    pfu Tongue 
paralysis 100% 
4 0 
Intracranial 10ul 105    pfu No paralysis 
100% Mortality 
0 100% 
Footpad 100ul 106    pfu Fore/rear limb 
paralysis 100% 
2-4 0 
 
 a  The route of injection of TMEV in CBA mice. 
 b  The amount of virus injected.  
 c  pfu injected 
 d  The incidence of paralysis or mortality observed in mice. URLP represents unilateral rear limb paralysis                  
and BRLP represents bilateral rear limb paralysis.  The percentage of mortality was only recognized in  
100% of the mice injected via the intracranial route.   
 e The onset of paralysis in CBA mice. 
 f The percentage of mice that suffered from encephalitis. 
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Clinical observations of gastrocnemius injection with TMEV  
Experimental evidence indicated a possibility of CNS invasion of TMEV by 
infection of skeletal muscle followed by entry of the virus via peripheral neural routes. 
Mice injected with GDVII Theiler’s virus into the left gastrocnemius muscle showed 
flaccid limb paralysis between days 5 – 6 p.i. similar to poliomyelitis in humans.  The 
initial state of paralysis was observed in the injected rear limb.  Most mice showed 
weakness of the injected rear limb by day 3 and 4 p.i.  A corresponding weakening of the 
contralateral rear limb was evident in 100% of mice that initially showed paralysis in the 
left gastrocnemius muscle with GDVII virus.  Weakening of the contralateral rear limb 
was evident on day 5 and 6 p.i.  Contralateral paralysis was not evident at the end of day 
6 p.i., however, the mice were not allowed to live past day 6 p.i.  It is likely that a 
contralateral paralysis have been clinically observed on days 7 and 8 p.i.  The results 
indicated that the spread of GDVII virus may occur from the periphery to the inferior 
spinal cord.  It is postulated that the virus then travels along interneurons where it then 
crosses over to the contralateral limb.  If this paralysis were allowed to progress, it is 
postulated a complete contralateral rear limb paralysis would likely have developed by 7 
or 8 p.i. (Table 2).  
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Effect of TMEV infection on sciatic nerve 
 The average of 2-4 toe spread in the left hind limb on days 1 and 2 pre-infection 
for the non infected group and the GDVII infected group was 6.3 mm (See materials and 
method for sciatic nerve model description).  The average toe spread of 2-4 in the left 
hind limb in the non-infected group remained at an average of 6 mm for the duration of 
the experiment.  The initial average width of 2-4 toe spread in the left hind limb of the 
GDVII infected group was 5.3 mm on day 1 p.i.  This average toe spread declined from 
5.3 mm to 4.8 mm from day 1 p.i. to day 2p.i.  There was a slight incline from day 2 to 3 
p.i. to 5.2 mm.  This is probably due to the time required for full recovery from 
anesthesia and surgery.  However, there was a steady decline in the width of 2-4 toe 
spread by day 4 p.i. and 5 p.i.  The average width was 4.8 mm.  The width continued to 
drop by day 6p.i. to 4.2 mm (Fig. 3(A)).  
Table 2.   Percentage of mice with clinical signs in IM injections 
Day 
No Clinicala     Functional Lossb     Left Limbc     Functional Lossd    Right Limbe 
Signs                of Left Limb           Paralysis        of Right Limb        Paralysis         
1     100                        0                          0                            -                    0 
2     100                        0                          0                            -                    0 
3       50                       50                         0                            -                    0 
4        0                       100                        0                            -                    0 
5        0                        50                       50                           +                     0 
6        0                         0                        50                           +                     0  
a Percentage of mice with no clinical signs 
b Percentage of mice with  functional loss of left limb 
c Percentage of mice with left limb paralysis 
d Percentage of mice with functional loss of right limb
e  Percentage of mice with right limb paralysis 
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 The average of 2-4 toe spread in the right hind limb days 1 and 2 pre-infection 
for the non infected group and the GDVII infected group was 6.3 mm. The average 2-4 
toe spread in the left hind limb in the non-infected group was 6 mm p.i, and it remained 
at this average for the duration of the experiment.  The initial average of 2-4 toe spread 
in the right hind limb of the GDVII infected group was 5.2 mm day 1 p.i.  The average 
2-4 toe spread in the GDVII infected group was 5.2 mm from day 1 p.i. to day 5 p.i.  
Between day 5 p.i. and day 6 p.i. the width declined to 4.7 mm (Fig. 3(B)).    
 The initial average width of 1-5 toe spread in the left hind limb of the non- 
infected group, and the GDVII infected group was 9.9 mm days 1 and 2 pre-infection.  
In the left hind limb of the GDVII infected group the average 1-5 toe spread declined to 
an average of 9.1mm day 1 p.i. and day 2p.i.  Between days 2 and 4 p.i. the width of 1-5 
toe spread remained at 9.1 mm.  There was a steady decline in the width from day 4 p.i. 
and day 6 p.i.  The width of 1-5 toe spread was 8 mm at day 6 (Fig. 4(A)).  The average 
1-5 toe spread in the non-infected group remained at 9.5 mm throughout the experiment.   
The average 1-5 toe spread in the right hind limb of the non-infected group, and 
the GDVII infected group days1 and 2 pre infection was 9.9 mm.  In the right hind limb 
of the GDVII infected group the toe spread declined to an average of 9.1 mm day 1 p.i. 
and day 2p.i.  There was an incline to 9.6 mm between days 2 and 4 p.i.  This is probably 
due to animal recovery from anesthesia and surgery.  Between days 4 and 5 p.i. the 
width of 1-5 toe spread declined to 9.1 mm.  The width continued to drop by day 6p.i. to 
8.6 mm (Fig. 4(B)).  The average 1-5 toe spread the right limb in the non-infected group 
remained at 9.5 mm the duration of the experiment. 
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Figure 3.  The effect of TMEV infection on 2-4 toe spread.  (A) 2-4 toe spread on 
left sciatic nerve function.  A steady decline in the width of 2-4 toe spread is 
evident by day 4 p.i. and 5 p.i.  ULRLP was observed at day 5 p.i.  (B) 2-4 toe 
spread on right sciatic nerve.  A steady decline in the width of 2-4 toe spread is 
evident by day 5 p.i.  In the time course experiment no incidence of clinical 
paralysis was observed in the right limb, however, contralateral rear limb paralysis 
was observed in the preliminary experiment (see Table 1).   
A 
B 
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Figure 4. The effect of TMEV infection on 1-5 toe spread.  (A) 1-5 toe spread on 
left sciatic nerve function.  A steady decline begins at day 4 - 5 p.i. The incidence 
of paralysis was observed in the left limb at day 5 p.i.  (B) 1-5 toe spread on the 
right sciatic nerve.  A steady decline begins at day 5 p.i.  
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Immunofluorescence results of the gastrocnemius muscle with TMEV 
Immunofluorescence was used to detect the neurotransmission of Theiler’s virus 
from the gastrocnemius muscle, to the sciatic nerve, spinal cord, and brain following 
intramuscular injection of Theiler’s virus. Viral antigen was detected in the 
gastrocnemius muscle, sciatic nerve, in the lumbar and cervical spinal cords.  No viral 
antigen was detected in the brain.   
Viral antigen was detected in the left gastrocnemius muscle on days 1 and 2 p.i. 
using purified rabbit anti-TMEV antibody by immunofluorescence staining (Fig. 5). The 
non-infected group and the infected group incubated with the secondary antibody 
demonstrated little to no signal (Fig. 5(A, B)).  Similar results were detected with the 
isotype controls and infected mice (Fig. 5(C, D)).  Due to the high background signal of 
the anti-TMEV antibody and the isotype antibody it was difficult to identify the virus in 
any muscle cells of the infected TMEV mice.  The virus was injected directly into the 
gastrocnemius muscle, therefore, it can be concluded that the virus was present in the 
muscle, but the exact localization of the virus is inconclusive.  
Viral antigen was detected in the sciatic nerve on days 2 and 3 p.i. using purified 
rabbit anti-TMEV antibody by immunofluorescence staining.  The non-infected group 
incubated with the purified rabbit anti-TMEV antibody and the infected group incubated 
with the secondary antibody only demonstrated little to no signal (Fig. 6(A ,B)).  Viral 
antigen was detected in the left sciatic nerves in three of the 4 mice sacrificed day 2 p.i 
(Fig 6(E)).  At day 2 and 3 p.i. viral antigen was isolated in immune cells of the sciatic 
nerve (Fig 6(C, D, F)).   
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Figure 5.  Immunofluorescent photomicrographs of cross sections illustrating left 
gastrocnemius muscle (GM) labeling.  The FITC fluorochrome is the green color observed 
that is used for GDVII labeling.  The DAPI fluorochrome is the blue color observed that is 
used for nuclei labeling.  Panel A was taken at 40X.  Panels B,C,D were taken at 10X.  (A) 
Labeled RBC in a non-infected (NIF) mouse incubated with anti-TMEV.  (B) GDVII 
infected (IF) mouse incubated with secondary control only.  (C) GDVII IF mouse incubated 
with isotype control. (D) GDVII IF incubated with anti TMEV.  Note that the staining 
patterns are different  in (C) compared to (D), however, the exact location of antigen was not 
localized in the infected muscle sections incubated with purified anti-TMEV.
C 
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Figure 6.  Immunofluorescent photomicrographs of cross sections illustrating left sciatic nerve 
labeling.  Panels A,C,D,E, & F were taken at 40X.  Panel B was taken at 10X.  (A) NIF mouse 
incubated with anti TMEV.  (B) GDVII IF incubated with secondary antibody only.  (C, D) 
GDVII IF section incubated with anti TMEV.  (C,D) Arrows point at viral antigen possibly 
isolated in immune cells day 2 and 3 p.i.  In panel (C) the labeling appears to be localized outside 
the axons.  In panel (D) the labeling appears to be localized in the axon.  (E) GDVII IF section  
incubated with anti TMEV.  Arrow points at viral antigen in axons.   (F) GDVII IF section 
incubated with anti TMEV Day 3 p.i.  Arrow is pointing at antigen labeling possibly localized in 
the axon.        
A B
C D 
E F
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A high background signal was seen in the isotype control (data not shown).  The 
fluorescent patterns seen in the isotype control were different than GDVII infected mice 
incubated with purified rabbit anti-TMEV antibody.  Therefore, localization of viral 
antigen was possible.      
Uptake of Theiler’s virus at motor nerve endings was confirmed by the detection 
of Theiler’s virus antigen in the left ventral horn neurons in the lumbar section of the 
spinal cord at day 3 p.i. (data not shown).  No staining patterns were seen in the isotype 
controls, secondary controls, and the non-infected mice (Figure 7 (A,B,C,)).  Viral 
antigen in the lumbar section was detected in the left limb of mice injected with 
Theiler’s virus.  Clinical observations of mice by day 3 p.i. showed evidence of a 
weakening of the inoculated limb, but not complete paralysis.  As clinical weakening of 
the ipsilateral limb progressed to the right limb, viral antigen was detected in the left side 
of the ventral lumbar spinal cord and also identified along the interneurons where it then 
crossed over to the contralateral rear limb and was detected in the right side of the 
ventral horn neurons of the spinal cord (Fig 7 (D,E)).  The neurotransmission of viral 
antigen was detected in the lumbar sections of 2 out of the 4 mice sacrificed on days 3 
p.i.  No viral antigen was detected in the cervical or thoracic sections of the spinal cord 
in any of the mice sacrificed on day 3 p.i. 
In the thoracic sections on days 4 and 5 p.i. viral positive neurons were 
identified, however not to the extent seen in the lumbar and cervical sections (data not 
shown).  Viral antigen was detected in the lower cervical spinal cord on days 5 and 6 p.i. 
using purified rabbit anti - TMEV antibody by immunofluorescence staining.   
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Figure 7.  Immunofluorescent photomicrographs of cross sections illustrating lumbar spinal 
cord labeling.  Panels A,B,C, & D were taken at 10X.  Panel E was taken at 63X. (A) NIF 
mouse incubated with anti TMEV.  The arrow points at the spinal canal.  (B) GDVII IF 
incubated with secondary antibody only.  (C) GDVII IF section incubated with isotype 
control.  (D) GDVII IF incubated with anti TMEV.  Viral labeling is evident in the left 
lumbar section and in the right ventral grey column were the lower motor neurons are 
located.  The arrow is pointing at unspecific labeling along the ventral median fissure.  (E) 
The insert is a higher magnification of viral antigen staining in cytoplasm of interneurons.  
C 
D E 
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Figure 8.  Immunofluorescent photomicrographs of cross sections illustrating cervical spinal 
cord labeling.  Panels A,B,C, & D were taken at 10X.  Panel E & F were taken at 63X. (A) 
NIF mouse incubated with anti TMEV.  (B) GDVII IF incubated with secondary antibody 
only.  (C) GDVII IF section incubated with isotype control.  (D) GDVII IF incubated with anti 
TMEV.  (E, F) Insert is higher magnification of viral antigen staining in cytoplasm of neurons.  
D 
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No staining patterns were seen in the isotype controls, secondary controls, and the non-
infected mice (Fig 8 (A, B, C)). Like those of the lumbar section, viral antigen was 
detected in the left side of the ventral lumbar spinal cord.  Viral antigen was also 
detected on the left side of the dorsal cervical spinal cord (Fig 8 (D, E)).  However, viral 
antigen was identified in the interneurons, where it was concluded to have crossed over 
to the contralateral right rear limb, and was detected in the right side of the ventral horn 
neurons and not the dorsal horn neurons (Fig 8 (F)).  Viral antigen was detected in the 
cervical sections of 1 out of the 4 mice sacrificed days 6 p.i.  No viral antigen was 
detected in the lumbar or thoracic sections of the spinal cord in any of the mice 
sacrificed on day 6 p.i.  
The motor neurons in the ventral horn neurons of spinal cord were the prominent 
cells that showed fluorescence in the lumbar spinal cord sections.  The viral antigen 
detected in the neurons was confined to the cytoplasm of the neurons.  No staining was 
identified in the nucleus of the neurons.  In the lumbar sections the localization of the 
fluorescence was related to the clinical signs of weakening or paralysis of the injected 
limb or contralateral limb, respectively.  Fluorescence was also evident in the cervical 
regions of the spinal cord; however, no weakening of the fore limbs was evident. One 
explanation is that the mice were sacrificed by day 6, and not allowed to progress to full 
clinical paralysis.  Results of the sciatic nerve model indicated a functional loss of the 
right hind limb at day 5 and 6 p.i.   
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H&E results of the gastrocnemius muscle with TMEV  
Histopathological review was performed following the intramuscular route of 
injection with GDVII Theiler’s virus.  Following the intramuscular route of injection 
H&E stained sections of the gastrocnemius muscle, sciatic nerve, spinal cord, and brain 
were observed.  Upon histological examination a varying severity of inflammatory cells 
were present between different days post-infection. The types of cells present in the 
gastrocnemius muscle ranged from cells of the innate immune response and acquired 
immune response.  The cells mainly observed were monocytes/macrophages based on 
their characteristic morphology.  Natural killer cells and mast cells were suspected to be 
present, however, they were not positively identified.  To a lesser extent scattered 
neutrophils were observed, however these were mainly confined to days 1 and 2 p.i.  
Similar to the gastrocnemius muscle, mast cells, natural killer cells, and 
monocytes/macrophages were observed in the sciatic nerve.  The lesions present in the 
CNS included mononuclear cell infiltrates and perivascular cuffs.  The extent of 
neuronal destruction was consistent with the severity of rear limb paralysis and 
weakening of the contralateral rear limbs.  
On day 1 p.i. of the gastrocnemius muscle a few immune cells were spread 
throughout the muscle (Fig. 9 (A)).  By day 2 p.i. a significant amount of mononuclear 
cell infiltrates were observed throughout the muscle (Fig. 9 (B,C,D)).  A few cells were 
also isolated in the connective tissue.  The immune cells were identified by their 
characteristic morphology.  Those cells clearly identified were monocytes and a few 
neutrophils.  By day 3 p.i. severe mononuclear cell infiltrates were evident in the 
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gastrocnemius muscle (Fig. 9 (E, F)).  Mononuclear cells were also observed along the 
nerve, however, most of the immune cells were localized in the muscle (Fig. 10 (B)).  By 
days 5, and 6 severe mononuclear cell infiltrates were evident along the connective 
tissue of a nerve and in the connective tissue bordering the muscle and nerve (Fig. 10 
(C)).  A significant number of monocytes/macrophage were seen in the muscle, and 
along the portions of the interstitial connective tissue between muscle bundles and a 
nerve attached to the muscle (Fig. 10 (D, E, F)).  No inflammatory infiltrates were seen 
in any of the non-infected groups (Fig. 10 (A)). 
In the sciatic nerve no significant amounts of inflammatory infiltrates were seen 
at day 1 p.i. (data not shown).  Inflammatory infiltrates were observed as early as day 2 
p.i. and 3 p.i.  By the 4th and 5th day p.i. a large number of inflammatory infiltrates were 
identified in the sciatic nerve (Fig. 11 (B)).  In addition, mast cells were also suspected 
to have invaded the sciatic nerve; however they were not positively identified (Fig. 12 
(C)).  Many cells were isolated in the connective tissue (Fig.  11 (D)).  The cells, mainly 
identified based on their morphological appearances, were monocytes/macrophages and 
natural killer cells.  No, inflammatory infiltrates were seen in any non-infected groups 
(Fig. 11 (A)). 
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Figure 9.  H&E photomicrographs of cross sections illustrating the gastrocnemius muscle 
(GM).  Panels A, B & E were taken at 10X and panels C,D, & F were taken at 63X.  (A) IF 
mouse GM section day 1 p.i. with little inflammatory cells.  (B) Inflammatory infiltration 
day 2 p.i.  (C,D) High mag of B of inflammatory infiltrates surrounding muscle fibers.  (D) 
The muscle fibers are necrotic and degenerated.  (E) IF mouse with severe inflammation 
day 3 p.i.  (F)  High mag. of inflammatory infiltration in the muscle.  The arrow points to 
necrotic muscle fibers.  
A B 
C D 
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Figure 10.  H&E photomicrographs of cross sections illustrating the gastrocnemius muscle.  
Panels A, B & C were taken at 10X.  Panels D, E, & F were taken at 63X.  (A) NIF mouse 
GM section.  (B) Inflammatory infiltration along the connective tissue of a nerve at day 3 p.i. 
(C) Infiltration along a nerve which also affects the surrounding muscle.  (D, E, F) High mag 
of (C) showing immune cells in the connective tissue surrounding a nerve.  (D, E, F) Arrows 
point at macrophage in the connective tissue.  Also scattered in the section are monocytes 
and neutrophills.  
A B 
C D 
E F
  
39
In the spinal cord no inflammatory infiltrates were evident on days 1, 2, and 3 p.i.  
On day 4 p.i, the animals that displayed unilateral left hind limb paralysis, showed 
histopathologically that there was inflammatory infiltration in the ventral side affecting 
the meninges in the ventral fissure (Fig. 12 (E)).  Perivascular cuffs were evident in both 
the left and right sides of the gray matter (Fig. 12 (C,F)).  Inflammatory mononuclear 
infiltrates were also evident in the gray matter of the left and right ventral horn in the 
lower lumbar segment of the spinal cord (Fig. 12 (C,D)).  In addition, those mice 
sacrificed on day 5 p.i had a significant amount of inflammatory infiltrates and neuronal 
loss was evident in the cervical spinal cords (Fig. 13 (A)).  The inflammatory cells 
invading the gray matter were found near or surrounding the neurons of the gray matter 
(Fig. 13 (B, E)).  Inflammatory mononuclear infiltrates as well as degenerated and 
necrotic neurons in the gray matter of the left dorsal horn neurons and the right ventral 
horn neurons in the cervical segment of the spinal cord were evident (Fig. 13 (B, E)).  
Inflammatory infiltration was also observed in meninges of ventral fissure (Fig. 13 (D)).  
Perivascular cuffs were evident in the both the left dorsal gray column and the right 
intermediate gray column (Fig 13 (B,C)).  Histopathological evaluation of mice that 
were sacrificed on day 6 p.i., indicated that inflammation was apparent throughout the 
lumbar and cervical sections of the spinal cord (data not shown).  In the spinal cord 
meningitis was most prominent in all of the sections.  Inflammatory infiltrates and 
perivascular cuffs were disseminated throughout the gray matter.  In contrast to the 
immunofluorescence results, the inflammation did not appear to be confined to a specific 
area in spinal cord.  
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Figure 11.  H&E photomicrographs of cross sections illustrating the sciatic nerve.  
Panels A & B was taken at 10X.  Panel C&D are at 63X.  (A) NIF mouse section.  (B) 
Inflammatory infiltration of the sciatic nerve.  (C) High mag of mouse section 
showing immune cells in the sciatic nerve.  (D) Arrows point at 
monocyte/macrophage.  
A B 
C D 
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Figure 12.  H&E photomicrographs of cross sections illustrating lumbar spinal cords. 
Panels A & B were taken at 5X.  Panels C,D, E, &F were taken at 63X.  (A) NIF mouse.  
(B) IF mouse section.  (C, D) High mag of B showing perivascular cuffs and microgliosis  
in the left ventral gray matter.  (E) Inflammatory infiltration of the meninges in the ventral 
fissure.  (F) High magnification of B showing perivascular cuffs in the right ventral side.  
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Figure 13.  H&E photomicrographs of cross sections illustrating cervical spinal cords. 
Panel A was taken at 5X.  Panel B,C, D & E were taken at 63X.  (A) IF mouse section .  
(B) High mag of B showing perivascular cuffs in the left dorsal gray column and 
microgliosis of the left dorsal gray column.  (C) High mag of B showing perivasuclar cuffs 
in the intermediate gray column.  (D) Inflammatory infiltration of the meninges in the 
ventral fissure.  (E) High magnification of B showing perivascular cuffs in the right ventral 
side.  
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Inflammation was apparent throughout the entire CNS of the mice sacrificed days 5 and 
6 p.i.  The clinical onset of unilateral hind limb paralysis and contralateral weakening of 
the right rear limb was on day 6 p.i.  Perivascular cuffing, microgliosis and necrotic 
neurons were evident the spinal cord sections.  Therefore, the severity and distribution of 
lesions in the spinal cord correlated with clinical disease.  Paralyzed animals invariably 
showed inflammation and neuronal degeneration in the spinal cord. 
Clinical observations of intranerve injection with TMEV 
The 12th cranial nerve or hypoglossal nerve is purely a motor nerve; 
consequently, in this study GDVII was injected into the hypoglossal nerve (Cranial 
nerve XII).  Experimental evidence indicates a possibility of CNS invasion of TMEV 
from the peripheral of CN XII by axonal transport.  Mice injected with GDVII Theiler’s 
virus into the left hypoglossal nerve displayed tongue paralysis ipsilateral to the injection 
site and/or  a prolapsed penis.  The penis of most males was prolapsed in those mice that 
displayed tongue paralysis, however, some of the mice displayed only tongue paralysis 
without a penile prolapse, and some mice suffered penile prolapse without tongue 
paralysis (Table 3).  The disease was not allowed to progress in those mice that 
displayed tongue paralysis.  
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Table 3.  Percentage of mice with clinical disease in IN injections 
Day No Clinical 
Signsa 
Tongue 
Paralysisb 
Penile 
Prolapsec 
Bothd 
1 100 0 0 0 
2 100 0 0 0 
3 100 0 0 0 
4 50 25 25 0 
5 25 25 0 25 
  
 
 
 
 
On days 1, 2 and 3 p.i. 100% of the inoculated mice appeared healthy.  On day 4 
p.i. 50% of the mice appeared healthy.  25% of the mice suffered tongue paralysis and 
the remaining two mice suffered a penile prolapse.  By day 5 p.i. only one mouse 
displayed tongue paralysis, and the remaining two mice displayed both tongue and 
penile prolapse.  One mouse appeared healthy on the last day p.i.  Clinical observations 
seen in mice that displayed tongue paralysis and/or a penile prolapse were similar to 
clinical observations seen in mice injected intracranially with GDVII Theiler’s virus 
(3,4, 5).  Initially mice demonstrated swelling of the eyelids followed by a productive 
mucous discharge. As the disease progressed, mice demonstrated neck and back arching.  
Immunofluorescence results of intranerve injection with TMEV 
Immunofluorescence was used to detect the neurotransmission of Theiler’s virus 
from the hypoglossal nerve, to the hypoglossal nucleus, cerebral cortex, optic nerve, 
other areas of the brain, and spinal cord following intranerve injection of Theiler’s virus.  
a  Percentage of mice with no clinical signs 
b  Pecenage of mice with tongue paralysis only 
c  Percentage of mice penile prolapse only 
d  mice that displayed both tongue paralysis and penile prolapse 
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In the medullary areas of the brain viral antigen was detected in the hypoglossal nerve, 
hypoglossal nucleus, the parasympathetic nucleus of the vagus nerve, and the reticular 
formation lateral to the hypoglossal nucleus.  In the rostral areas of the brain viral 
antigen was detected in the dorsal raphe nucleus.  No viral antigen was detected in the 
cerebral cortex or the spinal cord.   
  No viral antigen was detected in the cervical, thoracic, lumbar, or sacral regions 
of the spinal cord in any of the days post infection using purified rabbit anti-TMEV 
antibody by immunofluorescence staining (data not shown).  Results with the isotype 
controls and non-infected mice displayed similar results, which revealed no background 
staining or cross reactivity.  It is postulated that the virus was not localized in the spinal 
cord because it could not travel from the brain  to the spinal cord before the mice were 
sacrificed due to tongue paralysis or encephalitis.  
Viral antigen was localized in the hypoglossal nucleus and neighboring neurons 
at day 3 p.i. (Fig.  14 (A)).  The virus isolated in the hypoglossal nucleus was confined to 
the left hypoglossal nerve, and no viral antigen was present in the right hypoglossal 
nucleus (Fig. 14 (B)).  Results with the isotype control, secondary control, and non-
infected group contained little to no signal (Fig. 15 (A,B) ).  None of the signal was 
confined to the neurons in any of the negative controls.  At day  3 p.i. viral antigen was 
detected in neurons of the XII nucleus on the injected side, and a few stained neurons 
extended to the contralateral XII nucleus (Fig  14 (C,D)).  Viral antigen was seen in 
neurons neighboring the hypoglossal nerve and in the reticular formation  (Fig 14 (E,F)).  
The viral antigen detected in the neurons was confined to the cytoplasm of the neurons.  
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No staining was identified in the nucleus of the neurons.  No viral antigen was detected 
in the rostral area of the brain at day 1 and 2p.i  or (data not shown).  At day 3 p.i. and 4 
p.i.  viral antigen was detected  in numerous neurons of both the left and right neurons of 
the XII  nucleus (Fig.  15 (C,D)).  At this stage of disease virus antigen was also detected 
in the dorsal motor nucleus of the vagus nerve, which is situated above the hypoglossal 
nucleus.   
Minimal amount of labeling was evident in the metencephalon of the brain.  
Viral antigen was not detected in the metencephalon until the very rostral regions of this 
segment.  Viral antigen was localized along the axons of the trigeminal nerve and along 
the ventral spinal cerebellar tract as well (Fig. 16 (D,E,F) .  No viral antigen was 
detected in isotype and negative controls (Fig. 16 (A,B)).   At day 4 p.i. viral antigen was 
detected in the medial longitudinal fasciculus, and possibly surrounding cell bodies (Fig. 
17 (A,B)).  At day 4 p.i. viral antigen was also isolated in the left and right neurons of 
the pontine reticular nucleus ipsilateral and contralateral to the injection site (Fig. 17 (C, 
D)).  The labeling was spread out and may have affected cell bodies of the raphe magnus 
nucleus and the raphe pallidus nucleus.  Viral antigen was also detected in the left 
olivary nucleus, which may have extended to the subcoeruleus nucleus (Fig. 17 (E)).   
No labeling was seen in the olivary nuclei contralateral to the injection site (Fig. 17 (F)).  
No labeling was detected in the negative and isotype controls (data not shown).  No 
labeling was detected in the diencephalon, cerebral cortex, or optic nerve (data not 
shown).   
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Figure 14.  Immunofluorescent photomicrographs of cross sections illustrating 
mylencephalon labeling.  Each photomicrograph shows ipsilateral labeling.  Panels A,B,D, & 
E were taken at 10X.  Panel C & F were taken at 63X. (A,B) IF mouse incubated with anti-
TMEV.  Labeling is confined to XII n.  (C) 63X of (A) neurons and axons near the XII n. (D) 
GDVII IF section incubated with anti TMEV.  Neurons ipsilateral and a few contralateral to 
inj.  (D,E) GDVII IF incubated with anti TMEV.  (F) Insert is higher magnification of viral 
antigen staining in neurons of the reticular formation. 
A B 
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Figure 15.  Immunofluorescent photomicrographs of cross sections illustrating medullary  
labeling.  Each photomicrograph shows ipsilateral labeling.  Panels A,B,& C were taken 
at 10X.  Panel D, E, & F were taken at 63X. (A) NIF mouse incubated with anti TMEV. 
(B) GDVII IF incubated with isotype.   (C) GDVII IF incubated with anti TMEV 
Neurons ipsilateral and a contralateral to inj in the XII nu. (D) 63X of C neurons in the 
XII n. (D) 63X of C neurons in the ipsilateral XII n.  (F) 63X of C neurons in the 
contralateral XII n. 
A B 
C D 
E F
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Figure 16.  Immunofluorescent photomicrographs of cross sections illustrating labeling of 
the metencephalon.  Each photmicrograph shows ipsilateral labeling.  Panels A,B,C, &D 
were taken at 10X.  Panel E was taken at 40X.  Panel F was taken at 63X. (A) NIF mouse 
incubated with anti TMEV.  (B) IF mouse incubated with isotype control.  (C) IF mouse 
incubated with anti-TMEV with no labeling present.  (D) Left view of (C) labeling in 
arrow points at trigeminal tracts located in this area.  (E,F) High mag of (D) neurons and 
tracts labeled along the ventral spinal cerebellar tract and trigeminal axons.  
A B 
C D 
E F
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Figure 17.  Immunofluorescent photomicrographs of cross sections illustrating labeling 
of the mesencephalon.  Each photomicrograph shows ipsilateral and contralateral 
labeling.  Panels A, C, E & F were taken at 10X.  Panel B & D was taken at 63X. (A) 
IF mouse incubated with anti TMEV day 4 p.i.  (B) High mag of A.  (C) IF mouse 
incubated with anti TMEV day 4 p.i. possibly affecting the pontine reticular nu., raphe 
magnus nu., and raphe pallidus nu. located in this area.  (D) Left view of C labeling of 
neurons  (E) ipsilateral labeling arrows point to olivary nuclei and possibly affecting  
subcoeruleus nu.  (F) contralateral view of C.  
A B 
C D 
E F 
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H&E results of intranerve injection with TMEV 
The lesions present in the brain included presence of mononuclear cell infiltrates 
with and perivascular cuffing (nonsupprative encephalitis). The extent of inflammatory 
infiltrates was consistent with the clinical observations and immunofluorescence studies.  
Perivascular cuffs were seen in the hypoglossal nucleus near virally infected neurons  
(Fig. 18 (A,B)).   Microgliosis was evident near neurons of the hypoglossal nucleus (Fig. 
18 (C,D)).  No, inflammatory cells were evident in the non-infected controls (Fig 19 
(A)).  Inflammatory infiltrates were also seen along the dorsal meninges in the 
mylencephalon as early as day 2 p.i., and along the dorsal meninges were viral antigen 
was detected in the hypoglossal nucleus (Fig. 19 (B,C)).  Perivascular cuffs were seen 
near virus infected axons of the hypoglossal nerve ipsilateral to injection (Fig. 19 (E)).  
Perivascular cuffs were also seen contralateral to injection (Fig. 19 (F)).  In the more 
rostral regions of the brain, the inflammation was seen along the dorsal and ventral 
meninges at days 4 (data not shown). Inflammation correlated with the 
immunofluorescent results.  Inflammation was localized to the medial longitudinal 
fasciculus and surrounding cell bodies (Fig.  20 (A,B)).  Inflammation was also localized 
in the olivary nuclei and surrounding cell bodies (Fig 20 (C,D,E, & F).  No inflammation 
was isolated in the pontine nu. or the raphe nu.  No inflammation was detected in the 
diencephalon, cerebral cortex, or optic nerve (data not shown).    
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C D
Figure 18.  H&E photomicrographs of cross sections illustrating mylencephalon brain 
sections.  Panels A was taken at 5X.  Panel B, C, & D were taken at 63X (A) IF mouse 
section showing perivascular cuffs and inflammatory infiltrates in the ipsilateral XII nu. 
(B) High mag of (A) showing perivascular cuffs, microgliosis and dead neurons in the 
XII nu.  (C,D) High mag of (A) showing presence of inflammatory cells, microgliosis, 
perivascular cuffing, and dead neurons of the ipsilateral hypoglossal nu.  
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Figure 19.  H&E cross sections illustrating mylencephalon brain sections.  Panels A & 
B were taken at 5X.  (A) NIF mouse section .  (B) IF mouse section showing 
perivascular cuffs.   (C) High mag of B showing microgliosis located in the ipsilateral 
hypoglossal nu.  (D) High mag of B showing infiltration of inflammatory cells in the 
parasympathetic nu of X contralateral to injection.  (E) Perivascular cuff ipsilateral to 
infection (F) Perivascular cuffing contralateral to infection.  
 
A B 
C D 
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Figure 20.  H&E photomicrographs of cross sections illustrating mesencephalon brain 
sections.  Panels A & C were taken at 5X.  Panels B, D, E, & F are 63X.  (A) IF mouse 
section with inflammatory infiltrates.  (B) High mag of A illustrating inflammatory 
infiltrates in the medial longitudinal fasciculus and surrounding cell bodies.   (C) Low 
mag of A ventral mesencephalon.   (D,E) High mag of C showing inflammatory cells, 
microgliosis, and dead neurons of the olivary nuclei and surrounding cell bodies 
ipsilateral to injection.  (F) High mag of C illustrating  perivascular cuffs in the cell 
bodies rostral to the olivary nuclei.  
A B 
C D 
E F 
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DISCUSSION 
The development of paralytic disease caused by GDVII Theiler’s virus injected 
into the gastrocnemius muscle was investigated using susceptible mice.  The incidence 
of paralysis and the anatomical location of paralysis corresponded to the route of 
injection.  Left hind limb unilateral paralysis was observed following the intramuscular 
route of injection.  The mice showed clinical evidence of weakening of the contralateral 
limb.  These observations correlated with the results obtained from the sciatic nerve 
model.  In addition, the development of paralytic disease caused by GDVII Theiler’s 
virus injected into the left hypoglossal nerve (CN XII) was investigated using 
susceptible mice.  All mice injected in the hypoglossal nerve showed signs of tongue 
paralysis and/or penile prolapse.  This data indicates that intramuscular and intranerve 
inoculated with GDVII TMEV can enter the CNS by axonal transport and infect the 
motor neurons of the brain and spinal cord.   
It is suggested that the main viral dissemination route for GDVII Theiler’s virus 
includes direct invasion of the CNS from the bloodstream, or by infection of peripheral 
organs, such as muscle, followed by viral entry from these secondary sites via peripheral 
neural routes. The neural pathway is not suggested to be a main viral dissemination route 
for intravenously inoculated virus invasion of the CNS.  However, our results indicate 
that it may be critical in intramuscularly, intrafootpad, intratongue, and intranerve 
inoculated virus development of paralysis.  The elaborate studies reported in the time 
course experiment support the concept that GDVII Theiler’s virus may gain access to the 
CNS through a neural transport pathway.  After injection of GDVII virus in the left 
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gastrocnemius muscle, mice exhibited left hind limb paralysis followed by weakening of 
the contralateral limb.  In the preliminary results mice were allowed to progress to 
contralateral paralysis.  This studies indicates that GDVII can enter the sciatic nerve via 
the terminal motor branches that innervate the muscle.  Upon entry of GDVII into the 
sciatic nerve, the virus traveled in the retrograde direction to invade the lower motor 
neurons of the lumbar sections.  Once in the CNS the virus infected interneurons, and the 
lower motor neurons of the contralateral hind limb.  Immunohistochemical evaluation 
detected viral antigen in the lumbar regions of the spinal cord, interneurons, and 
contralateral side.  The virus traveled up the spinal cord to the thoracic and cervical 
regions.  Only a few positive neurons for viral antigens were detected in the thoracic 
region; however, viral antigen was detected in the cervical spinal cord.  Viral antigen 
was specifically detected in the upper motor neurons regions, and in the interneurons 
crossing to the upper motor neurons of the contralatereral side. 
The mechanism of entry of GDVII at nerve terminal remains unclear; however 
many substances that use the fast retrograde transport are thought to be packed in 
endosomes.  Experimental evidence suggests the cytoplasmic domain of the human 
poliovirus receptor (hPVR) associates with Tctex-1 [34, 35].  Tctex-1 is a proven light 
chain of cytoplasmic dynein motor complex.  It is known that the fast retrograde 
transport system is thought to be largely dependent on microtubules.  The microtubules 
of the cytoskeleton serve as tracks for the movement of most membrane bounded 
organelles and vesicles including Golgi, endosomes, mitochondria, secretory vesicles, 
and synaptic vesicles.  Two motor proteins of microtubules are used for the movement of 
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organelles from the cell center to the periphery (anterograde transport) requires kinesin, 
while dynein moves organelles from the periphery toward the cell center (retrograde 
transport) [36].  Additionally, collections of microtubules are also seen at the periphery 
of cells.  
Rabies virus is a neurotropic virus that has been studied for its ability to spread 
from a peripheral site to the CNS in the retrograde direction by axonal transmission [37]. 
Rabies virus is a small enveloped RNA virus that is classified as a member of the 
Rhabdoviridae family.  The direction of rabies transport into the CNS has been studied 
following i.c, i.m., ocular, nasal, and foot pad injections [37].  Following intramuscular 
injection of rabies virus, replication may occur first in the striated muscle cells.  The 
virus will then gain access to unsheathed neural endings in motor nerve end plates, and 
then spread along peripheral nerves to the CNS [37].   
In the intramuscular injections with TMEV the histopathological results 
correlated with the immunohistochemical results.  In the gastrocnemius muscle the cells 
identified were monocytes/macrophages and natural killer cells based on their 
morphological appearances.  These cells are seen in both the early and late immune 
response, and are actively involved in combating viral infection.  Viral localization was 
not clearly identified in the gastrocnemius muscle.  In spite of this, mononuclear cell 
infiltrates were located in the muscle and along the interstitial connective tissue located 
between the muscle fibers and an attached nerve.  The number of immune cells along the 
nerve increased by the 4th and 5th days’ p.i.  In the sciatic nerve monocytes/macrophages 
and natural killer cells were also identified based on their morphological characteristics.  
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In addition mast cells were also suspected to have invaded the sciatic nerve; however 
they were not positively identified.   
Mast cells are commonly involved in IgE-associated allergy infection, and in 
parasitic early immune responses [29, 38].  However, research suggests that they are 
actively involved in microbial infections.  In the early immune response they have been 
shown to play a role in the host immune response against gram-negative bacteria [39].  
In this study research supported evidence that mast cells can recognize and engulf 
bacteria.  This stimulates the release of cytokines such as IL-4, IL-6, and TNF-α.  These 
cytokines are important in the acute phase response and can trigger inflammation to 
respond to a bacterial infection.  In addition, certain progenitors of human mast cells 
express CD4 [40].  CD4 cell markers have been previously identified on T-helper cells, 
monocytes/macrophages.  These cell markers function in MHC class II responses and 
are also the Human Immunodeficiency Virus (HIV) receptor. HIV is a retrovirus that 
attacks these immune cells that contain CD4 receptors on their cell surfaces.  These 
receptors allow entry of HIV viral RNA into the cell.  Upon entry, an enzyme called 
reverse transcriptase will act as a template for its RNA to DNA transcription.  This will 
allow the viral RNA to be integrated into the cells DNA.  Mast cells that express CD4 
markers have shown to be infected with HIV-1 strain in the blood of AIDS patients [40].  
In addition, supporting research suggests mast cells can secrete IL-16 [41].  IL-16 is  a 
chemoattractant  for CD4 T-lymphocyte, and macrophage/monocytes,  IL-16 also 
inhibits HIV viral replication [41].   
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 The severity and distribution of lesions in the spinal cord correlated with clinical 
disease and the presence of TMEV viral antigen in immunohistochemical analyses.  In 
the CNS inflammation was apparent in the lumbar, thoracic, and cervical sections of the 
spinal cord.  The clinical onset of unilateral hind limb paralysis and contralateral 
weakening of the right rear limb correlated with the appearance of perivascular cuffing, 
lymphocyte infiltration.  Microgliosis, perivascular cuffing, and neuronal destruction 
were evident in the grey matter.  A number of necrotic cells were identified based on 
their morphological appearances.  Apoptotic cells were not identified, however, 
apoptotic cells have been identified in viral infection and neurological diseases such as 
Multiple Sclerosis.  In Theiler’s virus the presence of apoptotic cells has been studied 
during both the acute and chronic phase of disease [42, 43, 44, 45].  Specifically, one 
study examined the cell types involved during the acute phase of GDVII and DA virus 
infection, and the chronic phase of DA virus [42].  In the acute phase apoptotic cells 
were located in the neurons of both brain and spinal cord with both virus infections.  In 
the chronic phase apoptotic cells were identified in glial cells and oligodendrocytes in 
the white matter of the brain and spinal cord.  
As previously stated, mice injected intranerve showed signs of tongue paralysis 
and/or penile prolapse.  The hypoglossal nerve, or twelfth cranial nerve, is a somatic 
efferent (motor) nerve that innervates both intrinsic and extrinsic muscles of the tongue. 
In mice Theiler’s virus causes motor deficits; consequently the results would not be 
interfered by neighboring sensory fibers that are connected to the same interneurons. 
Mice injected in the hypoglossal nerve, displayed tongue paralysis.  This data suggest 
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that entry of GDVII Theiler’s virus into the CNS is through retrograde transneuronal 
transport of the virus from the XII motor neurons to their premotor interneurons and thus 
gains access to the CNS.   A number of studies have identified the hypoglossal nerve 
branches and the hypoglossal nucleus premotor branches using psuedorabies as 
transneural tracer or HRP retrograde labeling [46, 47].  Premotor braches have been 
identified in the parvocellular reticular formation, medullary reticular formation, the 
nucleus  of Kölliker-Fuse, and the reticular formation around the trigeminal (V) motor 
nucleus [47].  In more rostral reticular formation regions of the mylencephalon, labeling 
was identified in the nucleus gigantocellularis, raphe pallidus, and raphe magnus [46].  
In the pons or mid brain labeling was identified in the subcoeruleus nucleus and the 
motor trigeminal nucleus [46].  
The results identified in this study were slightly different.  Viral antigen was 
identified in the hypoglossal nerve, neurons of the XII nucleus on the injected side, and 
the contralateral XII nucleus, in the reticular formation lateral to the nucleus, and in the 
medullary reticular formation of the mylencephalon.  These results correlate with HRP 
and psuedorabies retrograde labeling.  However, in the later stages of disease viral 
antigen was also detected in the dorsal motor nucleus of the vagus nerve.  This nucleus is 
situated above the hypoglossal nucleus.  Viral antigen was also detected in the medial 
longitudinal fasciculus, which is located below the XII nucleus. This is most likely the 
result of neuronal destruction by the virus in adjacent surroundings not connected to the 
hypoglossal nucleus.  Viral antigen was detected in the more rostral regions of the mid 
brain surrounding the trigeminal nuclei.  The axons of the motor trigeminal nucleus 
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project to the muscles of mastication [48].  The axons of the pontine sensory nucleus of 
trigeminal nerve project tactile and proprioception to the face [48].  It may be difficult to 
evaluate any loss function due to CN 5 (trigeminal cranial nerve 5).   Upon clinical 
examination the mice suffered a mucous discharge.  This may have been the result of 
loss of sensation to blink or produce tears by the mouse.  However, the mucous 
discharge could have also been a result of dehydration due to weakening of the tongue 
and subsequently paralysis of the tongue.  A significant amount of viral antigen was 
detected in the mesencephalon region of the brain.  Viral antigen was localized in the 
medial longitudinal fasciculus, which contains axons of the vestibular nuclei and the 
abducent nucleus that coordinate eye movements for nystagmus [49].  In the ventral 
portion of the mesencephalon viral antigen was detected in the neurons of the pontine 
reticular nucleus ipsilateral and contralateral to the injection, and possibly the raphe 
magnus nucleus and the raphe pallidus nucleus.  It was difficult to isolate the exact 
boundaries of viral labeling.  Viral antigen was also detected in the left olivary nucleus, 
which extended to the subcoeruleus nucleus.   No viral antigen was detected in the 
diencephalons, cerebral cortex, or optic nerve.  This may be due to the fact that mice 
suffering from tongue paralysis and encephalitis, were sacrificed before further viral 
dissemination could occur.  
Similar studies using, Herpes simplex virus type 1 injected into the hypoglossal 
nerve demonstrated viral antigens in glial cells at the XII root entry zone, XII nucleus, 
the lateral reticular formation, Kölliker-Fuse nucleus, dorsal raphe nucleus, and nucleus 
coeruleus [50].  In contrast to this study no viral positive neurons were detected in the 
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dorsal motor nucleus of the vagus nerve, however, virally infected glial cells were 
located in this area.  In the lateral brainstem virus positive neurons were detected before 
the appearance of positive glial cells, and in the lateral reticular formation neurons were 
positive without positive glial cells [50].  This may indicate that glial cells were infected 
secondarily due to infection of the neurons.  These results indicated that the propagation 
of HSV via the hypoglossal nerve occurs mainly within the neural circuitry.  
The penis of most affected males was prolapsed.  Studies using pseudorabies as a 
transneuronal transport tracer to identify any existing CNS innervation of the penis, have 
demonstrated transneuronally labeled neurons in the reticular formation of the medulla, 
paraventricular nucleus of the hypothalamus [51].  The medullary reticular formation is 
located ventral to the hypoglossal nucleus.  The axons of CN XII also pass through the 
medullary reticular formation.  The medullary reticular formation contains axons for 
parasympathetic upper motor neuron axons to GVE LMNs in the sacral spinal cord [48].  
Viral antigen was detected in the medullary reticular formation which may have caused 
the clinical symptoms of prolapsed penis in the mice.    
The severity and distribution of lesions in the brain correlated with clinical 
disease and the presence of viral antigen in immunohistochemistry analyses.  In the brain 
inflammation was apparent in the hypoglossal nerve, bilateral in the hypoglossal 
nucleus, and dispersed throughout the reticular formation in the medullary area.  In the 
rostral areas of the brain microgliosis was evident near virally-infected neurons as well.  
Microgliosis, perivascular cuffing, and degenerated neurons were evident in the grey 
matter near neurons.  Moreover, intense areas of perivascular cuffs were evident near 
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viral positive neurons.  The clinical onset of tongue paralysis and penile prolapse 
correlated with the appearance of lymphocyte infiltration of the meningitis dorsal to 
affected areas.   
During normal physiologic conditions there is little evidence that supports the 
presence of circulating lymphocytes that can migrate through endothelial cells and gain 
entry into the CNS [52].  However, the hematogenous entry of an infectious agent into 
the CNS by crossing the BBB may be due to infection and replication in endothelial cells 
and/or macrophages. This may stimulate undifferentiated circulating macrophages to 
cross the BBB and become activated by the presence of IFN-γ released by resident glia 
[53].  The mononuclear cells can then upregulate the expression of MHC class II and 
therefore activate lymphocytes.  The BBB contains special structural and functional 
features of the brain capillaries that limit the access of materials from the blood into the 
brain and cerebral spinal fluid.  These specialized properties of the BBB include 
endothelial cells and their intercellular junctions that restrict vesicular transport and 
protect the CNS from harmful substances circulating in the blood.  
The CNS and the eye are immune privileged organs that developed in order to 
protect specialized tissue incapable of regeneration [53, 54].  Both have developed 
several mechanisms to maintain an immunologically privileged status.  The BBB 
controls immunity by regulating the entry of lymphocytes, and macrophages into the 
CNS [32, 53, 54].  Few tissues in the neural-ocular system contain bone-marrow derived 
cells that express MHC class II molecules, and these are limited in their antigen 
processing and presenting capabilities [53, 54].  Moreover, the eye and brain both lack 
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the conventional lymphatic drainage pathway, and therefore is highly specific to which 
inflammatory infiltrates can enter [52, 53, 54].  Therefore these organs do not elicit the 
same inflammatory response seen in non-privileged sites.  
In non-privileged sites pathogens will enter the body via many routes, but antigen 
and lymphocytes will eventually encounter each other in the peripheral lymphoid organs, 
which include the lymph nodes, the spleen, and associated mucosal lymphoid tissues 
[52].  Lymphocytes are continually present in these tissues.  Antigens are carried through 
infected tissues, primarily within antigen presenting cells (APC), macrophages and 
dendritic cells.  These cells are precursors from the bone marrow and express both class 
I and II major histocompatibility complex (MHC) molecules [52].  Naïve T cells become 
activated once APC process and present antigen to naïve T cells by means of the MHC 
class II complex or I [32, 52]. 
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CONCLUSION 
 There are two possible methods of entry into the central nervous system for 
TMEV; first by the hematogenous route and /or secondly the neural route.  Experiments 
for the future include similar detailed time course experiments using less virulent strains 
of TMEV, DA and Bean with respect to different routs of injection. With these models 
we hope to address the following experimental questions: 1) how do these viruses gain 
access to the CNS, and 2) once in the CNS how do these viruses spread? 
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MATERIALS AND METHODS 
TMEV 
The strain of GDVII Theiler’s virus used throughout this study was obtained 
from Dr. H. L. Lipton, Department of Neurology, University of Chicago, Evanston, IL.  
The GDVII strain of Theiler’s virus was amplified in L2 cells.  The culture supernatant 
that contained infectious virus was aliquoted and stored at -70˚C before use [55].    
Animals 
4 – 6 week old male CBA strain mice were used in this study (Harlan Sprague 
Dawley, Inc., Indianapolis, Indiana). They were housed in a BSL II containment animal 
room in the Laboratory Animal Resources and Research (LARR), College of Veterinary 
Medicine, Texas A&M University, TX.  
 Animal inoculations 
The mice were anesthetized with ketamine (100mg/kg) and xylazine (5mg/kg) 
via the intraperitoneal route.  Following administration of the anesthetic, the mice were 
injected with GDVII strain of Theiler’s virus into the intramuscular injection into the left 
medial gastrocnemius muscle, and intrahypoglossal nerve.  
Animal surgery 
Microsurgery was performed for the injection into the hypoglossal nerve and the 
intramuscular injection into the medial gastrocnemius muscle.  For the intrahypoglossal 
nerve injection, a sagittal incision was made in the skin from the intramandibular space. 
A longitudinal incision was made over the digastric muscle and mylohoidis muscle, and 
they were retracted downward in order to expose the XII nerve.  The nerve was carefully 
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abraded before the virus suspension was administered.  A 34-gauge needle was inserted 
into the nerve, and approximately .8ul to 1ul of the virus was slowly injected into the 
nerve.  The virus titer used was 108 p.f.u./ml.  Special care was taken during the surgery 
to keep the blood supply intact in order to avoid virus exposure to the blood stream.  The 
tissues around the nerve and the wound were then sutured. Each mouse was observed 
daily for any paralysis, including tongue paralysis and/or encephalitis, and sacrificed on 
day’s one, two, three, four, five, six, and seven days post infection, respectively. 
 For the intramuscular injection, the mouse was depilated on the left rear limb and 
placed under a dissecting microscope.  The skin on the ventral surface of the limb was 
cut along a line parallel with the gastrocnemius muscle.  The gastrocnemius muscle was 
exposed upon removal of subcutaneous connective tissue.  Similar to the nerve injection, 
the blood supply was kept intact in order to avoid virus exposure to the blood stream.  A 
27-gauge needle was used to inject 100ul of virus into the mouse. The virus titer used is 
106 p.f.u./ml. The wound was then sutured.  The mice were observed daily for paralysis 
and or clinical encephalitis, and sacrificed day’s one, two, three, four, and five days post 
infection, respectively.  
Sciatic nerve model 
In addition to the clinical observations obtained, a separate blind experiment was 
performed using a sciatic nerve model that determines functional loss of the sciatic 
nerve. This is a well established model that measures the length of  toe spread 1 - 5, and 
toe spread 2 - 4  [56, 57, 58].  In the lower limb the sciatic nerve divides into the tibial 
nerve and the peroneal nerve. As the mice progress to paralysis there is a decrease in the 
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width of toe spread between 1-5 and 2-4.  The toe spread between 2-4 is dependent on 
the tibial division of the sciatic nerve.  The toe spread between 1-5 is dependent on the 
tibial and peroneal division of the sciatic nerve.  The toe spread between 1-5 and 2-4 
were measured and the results were compared from injured and uninjured hind limbs.  
This experiment was also performed on non infected mice.  Blue ink was placed on the 
hind limbs of GDVII infected group and the non-infected group.   All mice were 
required to run on a white strip of paper along a column.  The width of toe spread 
between 1-5 and 2-4 were measured for both left and right limbs in the GDVII infected 
group and non-infected group.  The mice were measured up to 2 days prior to the 
infection and through the duration of the time course experiment.      
 Histopathology  
All mice inoculated with GDVII Theiler’s virus either intramuscular or 
intranerve were administered a lethal dose of phenobarbital intraperitoneally.  Mice were 
placed on a dissecting platform, and the thoracic cavity was dissected to expose the 
heart.  After cutting the right atrium using scissors, 15 to 20 ml of phosphate buffered 
saline (PBS) was slowly injected through the left ventricle.  Following PBS perfusion, 
15 to 20 ml of 10% buffered formaldehyde saline was slowly injected through the left 
ventricle.  The intact brain, spinal cord, and other tissues were immersed in 10% 
buffered formalin.  The tissues was processed in graded alcohol solutions and embedded 
in paraffin.  These slides were processed for H&E histology staining [59].  Slides that 
were unstained and used for immunohistochemistry were perfused with 15 to 20 ml of 
0.02 M PBS.  Following PBS perfusion, 15 to 20 ml of 2% paraformaldehyde was 
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perfused.  This procedure was used for immunohistochemistry in order to retain 
antigenicity.  The spinal cords were isolated and cut transversely through the cervical, 
thoracic, and lumbar sections.  Brains were cut horizontally at the cerebrum, mid-brain, 
and cerebellum.  The tissues were processed in graded alcohol solutions and embedded 
in paraffin.  These slides were then used for immunohistochemical analysis.  
Purification of rabbit anti-TMEV antiserum 
A solution of 100mg of antigen (GDVII) and .5 M of sodium phosphate 
(NaHPO4) was prepared.  10mg of antigen per milliliter of sepharose beads was used as 
recommended by the protocol for a high-capacity column [60,61].  The antigen-bead 
solution was mixed gently overnight at 4°C on a rocker.  The next day the antigen-bead 
solution was washed gently with 0.5M NaHPO4, 1M sodium chloride (NaCl), and again 
with 0.05 ethanolamine.  The beads were then incubated with 100mM ethanolamine 
overnight at 4°C on a gentle rocker.  The following day the beads were washed with 
PBS.  Anti TMEV antibody was diluted in 10mM of Tris, and then the antibody was 
passed down the antigen-bead column with a flow rate of approximately 1 ml/hr per 
each 1ml of column volume. After the antibody was captured on the antigen-bead 
matrix, the antibodies were washed with 10mM of Tris, 500 mM NaCl, and 10mM if 
Tris.  The antibodies were then eluted by high and low pH washes.  The acid pH cycles 
used 100mM of glycine that contained a pH of 2.5.  The solution was then treated with 
1M of Tris in order to raise the solution to a basic pH.  The elution conditions were kept 
mild in order to retain the antibody in its native state.  Approximately, 0.5ml was 
collected in separate tubes.  The presence of antibody was determined for each tube by 
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spectroscopy, and tubes with high concentration were combined.  The purified 
antibodies were dialyzed in order to completely remove the elution buffer.  Finally, an 
SDS electrophoresis gel as used in order to confirm the presence of the protein. 
Immunohistochemistry  
These sections were deparaffinized and 0.02M phosphate-buffered saline 
containing 0.3% Tween (PBST) used as a rinsing buffer and a dilution buffer.  
Following incubation with preimmune normal goat serum, the tissues were incubated 
with rabbit anti-TMEV polyclonal antiserum overnight.  The next day the sections were 
incubated for 45 minutes with the secondary antibody, Goat anti Rabbit IgG (H+L)-
biotin followed by 30 min incubation with FITC-streptavidin conjugate.  Sections were 
then washed 3 times for 3 minutes each with PBST.  The sections were incubated with 
prolong gold antifade that contained DAPI.  DAPI is a blue fluorochrome that labels 
nuclei.  The sections were then allowed to dry overnight and viewed for 
immunofluorescence labeling using a fluorescence microscope.  The NIF group was 
incubated with the same protocol as the IF group.  The isotype control used was a non-
specific rabbit anti IgG antibody.  The IF sections were incubated with the secondary 
antibody only and no primary antibody. 
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